Novo Nordisk A/SNVONYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P0
Near historical low
vs 3Y Ago
-1.7x
Contraction
Streak
4 yr
Consecutive declineDecelerating
PeriodValue
2025-58.38%
2024-0.50%
20239.17%
202234.69%
202159.41%
2020-15.98%
201910.39%
2018-0.97%
2017-18.80%
201625.61%